Correspondence 0001213900-23-098318 from Bluejay Diagnostics, Inc. (BJDX)

Bluejay Diagnostics, Inc.
Date: Dec. 22, 2023 · CIK: 0001704287 · Accession: 0001213900-23-098318

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-275697

Date

December 22, 2023

Author

H.C. WAINWRIGHT & CO., LLC

Form

CORRESP

Company

Bluejay Diagnostics, Inc.

Letter

Re: Bluejay Diagnostics, Inc.

December 22, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporate Finance

Washington, DC 20549

Registration Statement on Form S-1 (Registration No. 333-275697), as amended - Concurrence in Acceleration Request

Ladies and Gentlemen:

H.C. Wainwright & Co., LLC (“Wainwright”), solely acting as placement agent on a best efforts basis in an offering pursuant to the registration statement on Form S-1 (333-275697), as amended (the “Registration Statement”), hereby concurs in the request by Bluejay Diagnostics, Inc. that the effective date of the above-referenced registration statement be accelerated to 5:15 P.M. (Eastern Time), or as soon as practicable thereafter, on December 27, 2023, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.

Very truly yours,
H.C. WAINWRIGHT & CO., LLC

Show Raw Text

CORRESP
1
filename1.htm

December 22, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporate Finance

Washington, DC 20549

    Re:
    Bluejay Diagnostics, Inc.

    Registration Statement on Form S-1 (Registration No. 333-275697),
as amended - Concurrence in Acceleration Request

Ladies and Gentlemen:

H.C. Wainwright & Co.,
LLC (“Wainwright”), solely acting as placement agent on a best efforts basis in an offering pursuant to the registration
statement on Form S-1 (333-275697), as amended (the “Registration Statement”), hereby concurs in the request by Bluejay
Diagnostics, Inc. that the effective date of the above-referenced registration statement be accelerated to 5:15 P.M. (Eastern Time), or
as soon as practicable thereafter, on December 27, 2023, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is
aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.

    Very truly yours,

    H.C. WAINWRIGHT & CO., LLC

    By:
    /s/ Edward D. Silvera

    Name:
    Edward D. Silvera

    Title:
    Chief Operating Officer

SecProbe.io